Geldanamycin

Catalog No.S2713 Synonyms: NSC 122750

Geldanamycin Chemical Structure

Molecular Weight(MW): 560.64

Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.

Size Price Stock Quantity  
USD 170 In stock
USD 270 In stock
USD 670 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • Phenotypic effect of Genetic or Pharmacologic Compromise of the 477 Hsp70-StiA-Hsp90 Complex. The impact of each genetic modification on radial growth, conidiation, and response to various stress conditions was assessed after inoculation of a suspension of 104 conidia on glucose minimal medium (GMM) agar plates and incubation at 37ºC for 5 days.

    Antimicrob Agents Chemother, 2015, 10.1128/AAC.00946-15. Geldanamycin purchased from Selleck.

    C2C12 myoblasts were transfected with HA-tagged A17-PABPN1 constructs. Twenty-four hours post-transfection, cells were treated with CHX (10 μg/ml) alone or together with geldanamycin (2.5 μM) for the indicated times at 37°C. Lysates were blotted to show the expression of the proteins of interest. Band density was quantified and is shown in the line graph (right panels). Data are shown as the mean ± SEM (n = 5); **, P < 0.01.

    PLoS One, 2015, 10(9):e0138936.. Geldanamycin purchased from Selleck.

  • RT-qPCR analysis of eNOS mRNA and representative Western blot images of eNOS expression, respectively, in irradiated BAECs pretreated of geldanamycin (GA; 500 nM). At 12 h after 10 Gy irradiation, BAECs were harvested. The results suggest that both HSP90 is involved in the upregulation of eNOS in irradiated BAECs.

    Radiat Res, 2018, 189(5):519-528. Geldanamycin purchased from Selleck.

Purity & Quality Control

Choose Selective HSP (e.g. HSP90) Inhibitors

Biological Activity

Description Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
Targets
p185 [4]
(SKBr3 cells)
HSP90 (N-terminal domain) [1]
(Cell-free assay)
HSP90 [1]
(Cell-free assay)
70 nM 0.78 μM(Kd) 1.2 μM(Kd)
In vitro

Geldanamycin binds in the ATP-binding site in the N-terminus domain of Hsp90s (residues 1-220). Geldanamycin inhibits the ATPase activity of Hsp90 in a dose-dependent manner. [1] Geldanamycin causes a dose-dependent G2 arrest and reversible inhibiton o f entry into the S phase in A2780 human ovarian cell line. This inhibition is accompanied by p53 increase and finally demonstrated to be p53 dependent. [2] Geldanamycin causes polyubiquitination and proteasomal degradation of the p185 receptor protein-tyrosin kinase and shows a IC50 with 70 nM. [3, 4] Geldanamycin is a typical anti-tumor reagent, shows a mean GI50 with 0.18 μM against the panel of 60 human tumor cell lines. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A2780 cells NWfiRpFzWHKxbHnm[ZJifGmxbjDhd5NigQ>? NFHodm1Ed22yb4Xu[EB4[XNiZY\hcJVifGWmIH\vdkBidnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIH;2ZZJq[W5iY3HyZ4lvd22jIHPlcIwhdGmwZTDBNlc5OCxiSVO1NF0{NjRizszN M3Xub|EyPTF2MUS1
SW620 cell NY\aTIpDT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NHvMNIxKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gZYdicW6|dDDoeY1idiClb3zvdoVkfGGuIHPhdoNqdm:vYTDTW|YzOCClZXzsJIxqdmW|LDDJR|UxRTZwMjDuUS=> M3jDeVE2PjV6OEe5
MCF-7 cell MYLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NF3NWXNKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gZYdicW6|dDDoeY1idiCkcnXhd5Qh[2GwY3XyJG1ETi15IHPlcIwhdGmwZYOsJGlEPTB;Nj61JI5O NHrMZXMyPTZ3OEi3PS=>
SKBR3 cells M{fJWHBzd2yrZnXyZZRqd25iYYPzZZk> M{\v[lczKGh? NEf3PWJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIV{fHKxZ3XuJJJm[2WydH;yJIRm\mmlaXXueEBpfW2jbjDTT2JTOyClZXzsd{Bi\nSncjC3NkBpenNuIFnDOVA:QC53IH7N M3zOT|I{PjR6MUiw
MCF7 cells MYTQdo9tcW[ncnH0bY9vKGG|c3H5 NIHGU2c4OiCq MVvBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiZYjwdoV{e2mwZzDld5Rzd2enbjDy[YNmeHSxcjDh[pRmeiB5MjDodpMtKEmFNUC9PU45KG6P MYqyN|Y1QDF6MB?=
MDA-kb2 cells M{nYU2Z2dmO2aX;uJIF{e2G7 NXjJOWs2OThiaB?= M{XFfGlvcGmkaYTpc44hd2ZiSGPQPVAhcW5iaIXtZY4hVUSDLXviNkBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iZ3z1Z49kd3K2aXPvbYQhemWlZYD0c5Iu\GWyZX7k[Y51KGy3Y3nm[ZJie2ViZYjwdoV{e2mxbjDh[pRmeiBzODDodpMh[nliZnny[YZtgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGlEPTB;MUCgcm0> NEfPTIszPDl6NEmzOi=>
human SK-BR-3 cells NF;rNGlRem:uaX\ldoF1cW:wIHHzd4F6 MlTzRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCVSz3CVk0{KGOnbHzzMEBKSzVyPUG1Mlghdk1? MXexPVg6Pjh2OB?=
HUVEC cells M{PTb2N6fG:2b4jpZ:Kh[XO|YYm= NISyOY44OiCq NY\JS3R{S3m2b4TvfIlkcXS7IHHnZYlve3RiSGXWSWMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD1zOTDuUS=> MUeyOVI4PzB4Nx?=
human HCT116 cells MkXRS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NFfvOI1Iem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBJS1RzMU[gZ4VtdHNuIFfJOVA:OjFibl2= M1fHdlE5OjR|N{Cz
K562 cell MVXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M3jJ[mlvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IHj1cYFvKGyndXvlcYliKEt3NkKgZ4VtdCCuaX7ld{whUUN3ME2yNk4yKG6P Mof3NVU3PTh6N{m=
HT-29 cell NF\rW5FIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MUnJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCqdX3hckBkd2yxcnXjeIFtKGOjcnPpco9u[SCKVD2yPUBk\WyuIHzpcoV{NCCLQ{WwQVI1NjVibl2= MWCxOVY2QDh5OR?=
HCT116 cells M3rDU3Bzd2yrZnXyZZRqd25iYYPzZZk> MYnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiFVEGxOkBk\WyuczDifUBtfW2rbnXzZ4Vv[2ViYYPzZZktKEWFNUC9NE4xOyEQvF2= NFj0blEzOTZyNUm3OS=>
NCI-H1975 cells NUDzV5dLWHKxbHnm[ZJifGmxbjDhd5NigQ>? MoWzRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCQQ1mtTFE6PzViY3XscJMtKEmFNUC9N|Yhdk1? NXPPdYppOjF5MUWxOlU>
human DLD1 cells M2TMfmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NH7zZnBIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBFVERzIHPlcIx{NCCJSUWwQVM4KG6P NIjCVZMyQDJ2M{ewNy=>
human A431 cells NVnyPYdHS3m2b4TvfIlkyqCjc4PhfS=> NYDsPXhYPzJiaB?= Mn7uR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVQ{OSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUSwJI5O NUPGVYZWOjV{N{ewOlc>
human HepG2 cells Mn7OR5l1d3SxeHnjxsBie3OjeR?= NGnCRoM4OiCq MkH4R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVxTzJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME20NEBvVQ>? MUiyOVI4PzB4Nx?=
human BGC823 cells NXi0UnloS3m2b4TvfIlkyqCjc4PhfS=> M{\3SlczKGh? Ml;SR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRmdEQDJ|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9OFAhdk1? NXqzZ|JiOjV{N{ewOlc>
human SKBR3 cells NIfzWJBEgXSxdH;4bYPDqGG|c3H5 M{PKUFczKGh? Mm[zR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2tDWjNiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGy2aYTldk1odG9iYYPzZZktKEmFNUC9OFEhdk1? NInPTnMyQTRyNUWyPC=>
human MDA-MB-231 cells Mle3R5l1d3SxeHnjxsBie3OjeR?= NIDQPWY4OiCq NX:2cFNYS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUSDLV3CMVI{OSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUWwJI5O NYDaNmxCOjV{N{ewOlc>
human A549 cells NVzicJBIT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MnXyS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gRVU1QSClZXzsd{whT0l3ME22OEBvVQ>? NFq5W3EyQDJ2M{ewNy=>
Sf9 cells MXvGeY5kfGmxbjDhd5NigQ>? M1u3XWRqe3CuYXPlcYVvfCCxZjDHUU1DV0SLUGmg[pJwdSCqdX3hckBnfWyuIHzlcod1cCCKU2C5NEBidHCqYTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNvaX7m[YN1\WRiU3[5JINmdGy|IHHmeIVzKDF4IHjyd{BjgSCobIXvdoV{[2WwY3WgdI9t[XKrenH0bY9vKGG|c3H5MEBKSzVyPUe0JI5O Mmr3NlQ4PTF2NEG=
human U87MG cells MX;Qdo9tcW[ncnH0bY9vKGG|c3H5 M2\SbmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVUi3UWch[2WubIOsJGlEPTB;OEmgcm0> NV3vV3g4OjF5MUWxOlU>
human A549 cells NIPxXJpEgXSxdH;4bYPDqGG|c3H5 NH:xW204OiCq NYXDNJdsS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTV2OTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVk4KG6P MknqNlUzPzdyNke=
mouse P19 cells NV3vNW46S3m2b4TvfIlkyqCjc4PhfS=> NYDlbHB6OThiaB?= M4PqcGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJHAyQSClZXzsd{Bi\nSncjCxPEBpenNuIFnDOVA:OC5zIN88US=> MYOxO|Q1OjV4NR?=
human HL7702 cells NH\SZWtEgXSxdH;4bYPDqGG|c3H5 MlPJO|IhcA>? NULOS3pGS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEx5N{CyJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OC5zNEGg{txO M3HSTVI2Ojd5ME[3
human A549 cells MWPDfZRwfG:6aXRCpIF{e2G7 M2\4bFIh\GG7cx?= NHnYV3BEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KGGodHXyJFIh\GG7czDifUBCdGGvYYLCcJVmKGG|c3H5MEBKSzVyPUCuNVUh|ryP MWWyN|k1Pzd7NB?=
human A431 cells NWnCPXRNWHKxbHnm[ZJifGmxbjDhd5NigQ>? NGHvSZg4OiCq NYHSTHZtSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBOFMyKGOnbHzzJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjJizszN M1H1NFIxPjV3MkO3
human HepG2 cells NI\oR4VEgXSxdH;4bYPDqGG|c3H5 Ml;zR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVxTzJiY3XscJMh[nliTWTUJIF{e2G7LDDJR|UxRTBwMzFOwG0> NV\FNm96OjN4NU[1OVY>
human SW480 cells MnvaR5l1d3SxeHnjxsBie3OjeR?= NGXqVnc4OiCq Mli4R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV3c1QDBiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlMyKM7:TR?= MnrSNlUzPzdyNke=
human LNCAP cells MlnKR5l1d3SxeHnjxsBie3OjeR?= M1i0XFczKGh? NVWzWGhvS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVE6FQWCgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjR|IN88US=> MkDlNlUyODV7MkS=
human LS174T cells MofKR5l1d3SxeHnjxsBie3OjeR?= MVPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMV|E4PFRiY3XscJMh[nliTWTTJIF{e2G7LDDJR|UxRTBwNEWg{txO MYmxO|A{PDF|NR?=
human HeLa cells NFTONHFEgXSxdH;4bYPDqGG|c3H5 M2jPWVczKGh? NF;tNYVEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE44QThizszN M3jwUFI2Ojd5ME[3
rat L6 cells MorPR5l1d3SxeHnjxsBie3OjeR?= NILvTI04OiCq NUPvTXo5S3m2b4TvfIlkcXS7IHHnZYlve3RicnH0JGw3KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDBcIFu[XJiQnz1[UBie3OjeTygTWM2OD13IN88US=> M4n6[|I1PThyNUOx
human MCF7 cells NEi2UWpEgXSxdH;4bYPDqGG|c3H5 NYnUfIhDS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCkeTDTVmIh[XO|YYmsJGlEPTB;OT62JO69VQ>? NWL3cpNkOTl3NkCzOVM>
human MCF7 cells NHewcHdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M3\MeWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKg[IF6eyCkeTDTVmIh[XO|YYmsJGdKPTB;M{WuOkDPxE1? NETLN2MyPzh4OUC5PC=>
HEK293T cells MlTTSpVv[3Srb36gZZN{[Xl? MWjJcohq[mm2aX;uJI9nKFSQRj3hcJBp[S2rbnT1Z4VlKE6ILXvhdJBiSiCjY4TpeoF1cW:wIHX4dJJme3OnZDDpckBJTUt{OUPUJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? Ml;PNVg1ODh5MUO=
human Jurkat cells NVH5RpRpTnWwY4Tpc44h[XO|YYm= NX2yRnVmUW6qaXLpeIlwdiCxZjDUUmYu[WyyaHGtbY5lfWOnZDDOSk1s[XCyYVKgZYN1cX[jdHnvckBmgHC{ZYPz[YQhcW5iRlHESEBl\W[rY3nlcpQhcHWvYX6gTpVzc2G2IHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> MXmxPFQxQDdzMx?=
human SKBR3 cells MkK5SpVv[3Srb36gZZN{[Xl? MoHLNlQhcA>? MlqzTY5pcWKrdHnvckBw\iCKc4C5NE1u\WSrYYTl[EBJTVJ{IHTl[5Ji\GG2aX;uJIlvKGi3bXHuJHNMSlJ|IHPlcIx{KGGodHXyJFI1KGi{czDifUBY\XO2ZYLuJIJtd3R? NGjCcZYyQDhzNkGxNS=>

... Click to View More Cell Line Experimental Data

In vivo Geldanamycin (50 mg//kg) shows 30% inhibition on pl85-associated phosphotyrosine levels in FRE/erbB-2 mice. [6]

Protocol

Kinase Assay:

[1]

+ Expand

Isothermal Titration Calorimetry (ITC) of Nucelotide Binding:

The titration experiments are performed using the MSC system. In each experiment, 16 aliquots of 15 μL of geldanamycin (300 μM in 1% DMSO) are injected into 1.3 mL of protein (31 μM in 20 mMTris-HCl, pH 7.5, 1 mMEDTA) at 25 °C, and the resulting data are fit after subtracting the heats of dilution. Heats of dilution are determined in separate experiments from addition of geldanamycin into buffer and buffer into protein. No evidence for binding of DMSO in the nucleotide binding site is observed. Titration data are fit using a nonlinear least-squares curve-fitting algorithm with three floating variables: stoichiometry, binding constant (Kb) 1/Kd), and change of enthalpy of interaction (ΔH°). Dissociation constants estimated for geldanamycin binding to intact yeast Hsp90 is 1.22 μM, and for binding to Hsp90 N-terminal domain is 0.78 μM. No meaningful heat is observed with binding to the C-terminal fragment.
Cell Research:

[2]

+ Expand
  • Cell lines: A2780 human ovarian cell line
  • Concentrations: 0.001-10 μM
  • Incubation Time: 3 hours
  • Method:

    Exponentially growing cells are treated with Geldanamycin and at various times DNA synthesis is assessed by incorporation of bromodeoxyuridine (BrdUrd) and flow cytometric analysis. No marked difference in total cell number is noted during this time course for treated and untreated cultures. BrdUrd (10 μM) is incorporated over a 4-h incubation period at 37 °C and cells are harvested and fixed in 70% ethanol. After denaturation of the DNA with 2 N HC1, cells are incubated with an anti-BrdUrd mouse monoclonal antibody followed by a fluorescein isothiocyanate (FITC)-linked goat anti-mouse IgG. Cells are stained for 30 minutes at room temperature with propidium iodide and analysed by flow cytometry using a Coulter EPICS Profile Analyzer.


    (Only for Reference)
Animal Research:

[6]

+ Expand
  • Animal Models: FRE/erbB-2 tumors in nu/nu mice
  • Formulation: Geldanamycin is dissolved in DMSO.
  • Dosages: 50 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 36 mg/mL warmed (64.21 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 560.64
Formula

C29H40N2O9

CAS No. 30562-34-6
Storage powder
in solvent
Synonyms NSC 122750

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

HSP (e.g. HSP90) Signaling Pathway Map

HSP (e.g. HSP90) Inhibitors with Unique Features

Related HSP (e.g. HSP90) Products4

Tags: buy Geldanamycin | Geldanamycin supplier | purchase Geldanamycin | Geldanamycin cost | Geldanamycin manufacturer | order Geldanamycin | Geldanamycin distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID